Vol 7 Issue 12

CELL AND GENE THERAPY INSIGHTS

December 2021 Issue

Vol 7 Issue 12

Download PDF

Featuring

Issue Spotlight: Tools of tomorrow
Starting material collection & optimization 2022
Other articles

SPOTLIGHT

Tools of tomorrow

Innovator Insight

Accelerating gene therapy development: from concept to clinic

Accelerating gene therapy development: from concept to clinic

Steven Gill, Qian Lui, Ryan Cawood
20 January 2022
Read
Success strategies for cell and gene therapy 3.0

Success strategies for cell and gene therapy 3.0

Joe DePinto, Richard Gaeto
14 December 2021
Read

Interview

Driving development and commercialization of iPSCderived allogeneic T cell therapies

Driving development and commercialization of iPSCderived allogeneic T cell therapies

David Dow
31 January 2022
Read
Unlocking barriers to further gene therapy success in eye disease

Unlocking barriers to further gene therapy success in eye disease

Jed Chatterton
6 January 2022
Read
Innovation in rAAV gene therapy is a need: AAV capsids

Innovation in rAAV gene therapy is a need: AAV capsids

Lester Suarez
16 December 2021
Read

FastFacts

Biacore™ systems for viral vector titer analysis

Biacore™ systems for viral vector titer analysis

Anna Moberg
5 January 2022
Read
Rapid Quantitation of Viral Vectors with Simple Plex Microfluidic Immunoassays

Rapid Quantitation of Viral Vectors with Simple Plex Microfluidic Immunoassays

Nathan Steere
20 December 2021
Read
Process development and scale-up of pluripotent stem cell manufacturing

Process development and scale-up of pluripotent stem cell manufacturing

Gary M Pigeau PhD
16 December 2021
Read

Viewpoint

Process analytical technology tools for process monitoring in CGT product manufacturing

Process analytical technology tools for process monitoring in CGT product manufacturing

Wai Lam W Ling, Arun C Patel
18 January 2022
Read

Supply Chain FOCUS

Starting material collection & optimization 2022

Expert Insight

Umbilical cord blood NK cells offer multiple advantages for cancer immunotherapy: lessons learned from Glycostem’s orphan drug oNKord®

Umbilical cord blood NK cells offer multiple advantages for cancer immunotherapy: lessons learned from Glycostem’s orphan drug oNKord®

Volker Huppert
14 January 2022
Read
Navigating regulations to provide ethically sourced cellular material for research and development: UK perspective

Navigating regulations to provide ethically sourced cellular material for research and development: UK perspective

Salmah Ahmed
11 January 2022
Read

Interview

Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing

Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing

Heidi Elmoazzen, PhD
11 January 2022
Read

Innovator Insight

Considerations for developing scalable and efficient collection network processes

Considerations for developing scalable and efficient collection network processes

Lacey Anderson, Sara Butler, Allison Montalvo
11 January 2022
Read

Journal articles

Editorial

Cell and gene therapy approvals soar in the first half of 2021

Cell and gene therapy approvals soar in the first half of 2021

Christopher A Bravery
20 December 2021
Read

Perspective

Demonstrating Comparability of AAV Gene Therapy Products During Clinical Development: Managing the Link Between the Product and the Process

Demonstrating Comparability of AAV Gene Therapy Products During Clinical Development: Managing the Link Between the Product and the Process

Niamh Kinsella, Clare Blue
16 December 2021
Read

Innovator Insight

Accelerating analytical testing for GMP plasmid production

Accelerating analytical testing for GMP plasmid production

Paul Mania
20 January 2022
Read
Achieving high non-viral transfection performance for cell therapy processing

Achieving high non-viral transfection performance for cell therapy processing

Nektaria Andronikou, Joseph Fraietta, Theo Roth
27 January 2022
Read
Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Tracy Moore
7 February 2022
Read

Interview

US FDA perspective: getting back into high gear – driving cell and gene therapy forward through 2022 and beyond

US FDA perspective: getting back into high gear – driving cell and gene therapy forward through 2022 and beyond

Peter Marks
20 December 2021
Read
Therapeutic potential of extracellular vesicles

Therapeutic potential of extracellular vesicles

A Kauffman, P Chiang, L Hsu et al.
24 January 2022
Read

FastFacts

Stable lentiviral vector producer cell line for a scalable manufacture

Stable lentiviral vector producer cell line for a scalable manufacture

Roy Liu
2 December 2021
Read
Fast chromatography of AAV – purification and analytics

Fast chromatography of AAV – purification and analytics

Maja Leskovec
20 December 2021
Read

Infographic

Therapeutic potential of extracellular vesicles poster

Therapeutic potential of extracellular vesicles poster

24 January 2022
Read